Duquesne Family Office LLC
Institutional investor · Portfolio as of Q4 2018
Top Holdings31 positions
Microsoft Corp | 4.6M | $469.1M | 27.2% | $93.93 | 0.00% | 1 qtr | First report 0 |
Amazon.com Inc | 98,428 | $147.8M | 8.6% | $73.90 | 0.00% | 1 qtr | First report 0 |
salesforce.com Inc | 1.1M | $146.9M | 8.5% | $133.06 | 0.00% | 1 qtr | First report 0 |
Tesla Inc | 299,800 | $99.8M | 5.8% | — | — | — | First report — |
Abbott Laboratories | 1.3M | $93.7M | 5.4% | $62.58 | 0.00% | 1 qtr | First report 0 |
Workday Inc | 525,400 | $83.9M | 4.9% | $159.56 | 0.00% | 1 qtr | First report 0 |
Coupa Software Inc | 1.1M | $71.1M | 4.1% | — | — | 1 qtr | First report 0 |
Adobe Systems Inc | 301,015 | $68.1M | 3.9% | $223.13 | 0.00% | 1 qtr | First report 0 |
iShares MSCI Emerging Markets ETF | 1.7M | $65.6M | 3.8% | $33.39 | 0.00% | 1 qtr | First report 0 |
Gilead Sciences Inc | 1M | $64M | 3.7% | $47.26 | +219.87% | 1 qtr | First report 0 |
Intuitive Surgical Inc | 110,300 | $52.8M | 3.1% | $157.07 | 0.00% | 1 qtr | First report 0 |
Illumina Inc | 139,500 | $41.8M | 2.4% | $290.11 | 0.00% | 1 qtr | First report 0 |
PayPal Holdings Inc | 408,535 | $34.4M | 2.0% | $83.07 | 0.00% | 1 qtr | First report 0 |
Medtronic PLC | 372,500 | $33.9M | 2.0% | $74.08 | +19.44% | 1 qtr | First report 0 |
ISHARES TR | 350,300 | $33.8M | 2.0% | $93.02 | 0.00% | 1 qtr | First report 0 |
Delta Air Lines Inc | 626,600 | $31.3M | 1.8% | $46.57 | 0.00% | 1 qtr | First report 0 |
Alibaba Group Holding Ltd | 174,400 | $23.9M | 1.4% | $132.09 | 0.00% | 1 qtr | First report 0 |
AC IMMUNE SA | 2.5M | $23.5M | 1.4% | $9.78 | 0.00% | 1 qtr | First report 0 |
MercadoLibre Inc | 74,016 | $21.7M | 1.3% | $292.85 | 0.00% | 1 qtr | First report 0 |
Netflix Inc | 66,010 | $17.7M | 1.0% | $25.61 | 0.00% | 1 qtr | First report 0 |
Duquesne Family Office LLC manages $1.7B across 31 positions as of Q4 2018. Top holdings: MSFT (27.2%), AMZN (8.6%), CRM (8.5%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1.5/5.0.
First quarter we have for this fund: 31 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $1.7B across 31 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR